1,313 results on '"Gøtzsche, Peter C."'
Search Results
2. CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomized trials
3. Clinical trials were missing from regulatory documents of extended-release methylphenidate for ADHD in adults: a case study of public documents
4. WHO Essential Medicines List and methylphenidate for ADHD in children and adolescents
5. Interventions to help patients withdraw from depression drugs: A systematic review.
6. Can screening work?
7. Extraordinary exaggerations
8. The Lancet publishes the harms of screening
9. Celebrating 20 years of breast screening in the United Kingdom
10. US and Swedish 2002 meta-analyses
11. Introduction
12. Important issues in cancer screening
13. Falsehoods and perceived censorship in Sweden
14. Delayed media storm in the United States after our 2001 reviews
15. Overdiagnosis and overtreatment
16. Troubling results in the Lancet
17. Editorial misconduct in the European Journal of Cancer
18. The Danish National Board of Health circles the wagons
19. Where next?
20. Tabár's ‘beyond reason' studies
21. Tabár threatens the BMJ with litigation
22. Scientific debates in the United States
23. Publication of entire Cochrane review obstructed for 5 years
24. Other observational studies of breast cancer mortality
25. Stonewalling the Cochrane report on screening
26. Where is screening at today?
27. What have women been told?
28. Ad hominem attacks: a measure of desperation?
29. Does screening work in Sweden?
30. Harms dismissed by the Cochrane Breast Cancer Group
31. US recommendations for women aged 40–49 years
32. Cross-sectional study of medical advertisements in a national general medical journal: evidence, cost, and safe use of advertised versus comparative drugs
33. Are investigators’ access to trial data and rights to publish restricted and are potential trial participants informed about this? A comparison of trial protocols and informed consent materials
34. Correction to: Cross-sectional study of medical advertisements in a national general medical journal: evidence, cost, and safe use of advertised versus comparative drugs
35. Interventions to help patients withdraw from depression drugs: A systematic review
36. Psychopharmacology Is Not Evidence-Based Medicine
37. Strategies for obtaining unpublished drug trial data: a qualitative interview study
38. Suspicions of possible vaccine harms must be scrutinised openly and independently to ensure confidence
39. The Yusuf-Peto method was not a robust method for meta-analyses of rare events data from antidepressant trials
40. Review of invitations to publish in predatory scientific journals
41. CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials
42. CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomized trials
43. Benefits and harms of the human papillomavirus (HPV) vaccines: comparison of trial data from clinical study reports with corresponding trial register entries and journal publications
44. Benefits and harms of the human papillomavirus (HPV) vaccines: systematic review with meta-analyses of trial data from clinical study reports
45. Clinical trials, abroken social contract with patients
46. Busting the industry myths
47. Merck, where the patients die first
48. Impotent drug regulation
49. Generalsystem failure calls for a revolution
50. Organised crime, the business model of big pharma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.